EMBL institutional partnerships are close cooperative affiliations between EMBL and external institutions of comparable standard, vision and international orientation. Working relationships at the institutional level are based on shared institutional goals and scientific synergy or complementarity. The aim is to leverage the EMBL model together with the strengths of the partners, to create an interlinked system of excellent institutions that enhance molecular life science in Europe and the world. Read more about EMBL Partnerships in the FAQ >
Involving institutions on or near EMBL campuses, benefiting from shared infrastructure and equipment.
Implementing EMBL’s research strategy and operational model on the national level in member states.
Heidelberg, 12 September 2016 New EMBL-Hubrecht Institute partnership EMBL and the Hubrecht Institute in Utrecht, the Netherlands, have signed an agreement establishing the EMBL-Hubrecht Partnership for Stem Cell and Tissue Biology. Building upon existing links between the two organisations, the partnership aims to establish a working relationship to support scientific exchange and complementarity. Working at the interface of stem cell and tissue biology, researchers in this partnership will investigate how human tissues and organs develop and are organised, advancing our understanding of a wide range of diseases, including heart degeneration, Alzheimer's, diabetes and tumours.
Heidelberg, 14 July 2016 How new HIV drugs lock virus in immaturity A new type of HIV drug currently being tested works in an unusual way, scientists in the Molecular Medicine Partnership Unit, a collaboration between EMBL and Heidelberg University Hospital, have found. Led by John Briggs at EMBL and Hans-Georg Kräusslich at Heidelberg University Hospital, they also discovered that when the virus became resistant to early versions of these drugs, it did not do so by blocking or preventing their effects, but rather by circumventing them. The study, published online in Science, presents the most detailed view yet of part of the immature form of HIV.
Grenoble, 7 June 2016 Partnership for Structural Biology: strength in diversity The Partnership for Structural Biology (PSB) brings together researchers working at various institutes based at the European Photon and Neutron (EPN) science campus in Grenoble. Through the PSB, researchers based at EMBL, ILL, ESRF, and the Institut de Biologie structural (IBS) can collaborate with and access resources and expertise from all institutes. The PSB agreement was renewed for five more years in February 2016, strengthening the position of EMBL and the other members of the Grenoble-based partnership as leaders in protein studies.
General, 29 September 2015 Northern highlights EMBL’s remote partnerships with national institutes in the member states are ‘remote’ only in name: these collaborations aim to belie borders, unifying scientists and complementary science to spur transfer of research excellence and know-how in training, governance and recruitment. Recent activities in the Nordic countries demonstrate how effective these networks have become: renewal of EMBL’s partnership with the Sars International Centre for Marine Molecular Biology in Norway for a further 10 years, and the annual meeting of the Nordic EMBL Partnership for Molecular Medicine.
Heidelberg, 28 July 2015 Union makes success With the goal of joining forces to further scientific and medical research, EMBL and the Medical Faculty of the University of Heidelberg have renewed the successful Molecular Medicine Partnership Unit (MMPU) agreement until 2025. The two complementary research institutions will continue to share data and resources, and together achieve scientific and medical breakthroughs that each individually may not have been able to make. “This kind of close collaboration really bridges the gap between basic and medical research and brings strong additional value to both institutions,” explains Matthias Hentze, Director of EMBL.